Use of CXCL9 as a Biomarker of Acthar Efficacy
Not yet recruiting
Phase of Trial: Phase IV
Latest Information Update: 07 Oct 2016
At a glance
- Drugs Corticotropin (Primary) ; Corticotropin (Primary)
- Indications Sarcoidosis
- Focus Biomarker; Therapeutic Use
- 03 Oct 2016 Planned initiation date changed from 1 Aug 2016 to 1 Oct 2016.
- 23 May 2016 Planned initiation date changed from 1 Oct 2015 to 1 Aug 2016.
- 20 Aug 2015 The drug dosage has been changed, according to the ClinicalTrials.gov record.